Computational Assessment of Pharmacokinetics and Biological Effects of Some Anabolic and Androgen Steroids

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2018 Feb 7

PMID 29404794

Citations 20

Authors

Marin Roman

Diana Larisa Roman

Vasile Ostafe

Alecu Ciorsac

Adriana Isvoran

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study is to use computational approaches to predict the ADME-Tox profiles, pharmacokinetics, molecular targets, biological activity spectra and side/toxic effects of 31 anabolic and androgen steroids in humans.

Methods: The following computational tools are used: (i) FAFDrugs4, SwissADME and admetSARfor obtaining the ADME-Tox profiles and for predicting pharmacokinetics;(ii) SwissTargetPrediction and PASS online for predicting the molecular targets and biological activities; (iii) PASS online, Toxtree, admetSAR and Endocrine Disruptomefor envisaging the specific toxicities; (iv) SwissDock to assess the interactions of investigated steroids with cytochromes involved in drugs metabolism.

Results: Investigated steroids usually reveal a high gastrointestinal absorption and a good oral bioavailability, may inhibit someof the human cytochromes involved in the metabolism of xenobiotics (CYP2C9 being the most affected) and reflect a good capacity for skin penetration. There are predicted numerous side effects of investigated steroids in humans: genotoxic carcinogenicity, hepatotoxicity, cardiovascular, hematotoxic and genitourinary effects, dermal irritations, endocrine disruption and reproductive dysfunction.

Conclusions: These results are important to be known as an occupational exposure to anabolic and androgenic steroids at workplaces may occur and because there also is a deliberate human exposure to steroids for their performance enhancement and anti-aging properties.

Citing Articles

Predictions of the Biological Effects of the Main Components of Tarragon Essential Oil.

Pujicic A, Popescu I, Dascalu D, Petreus D, Isvoran A Int J Mol Sci. 2025; 26(5).

PMID: 40076487 PMC: 11899843. DOI: 10.3390/ijms26051860.

Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives.

Santos B, de Souza J, de Paula Goulart L, Petrine J, Alves F, Del Bianco-Borges B Saudi Pharm J. 2024; 32(12):102205.

PMID: 39697477 PMC: 11653648. DOI: 10.1016/j.jsps.2024.102205.

Anabolic-androgenic steroids are linked to depression and anxiety in male bodybuilders: the hidden psychogenic side of anabolic androgenic steroids.

Karagun B, Altug S Ann Med. 2024; 56(1):2337717.

PMID: 38590148 PMC: 11005876. DOI: 10.1080/07853890.2024.2337717.

Effects of Nandrolone Decanoate on Skeletal Muscle and Neuromuscular Junction of Sedentary and Exercised Rats.

Tiburcio F, Leite A, Muller K, Pinto C, Valentino E, Castro P Medicina (Kaunas). 2023; 59(11).

PMID: 38003989 PMC: 10673219. DOI: 10.3390/medicina59111940.

Anabolic androgenic steroids and cardiomyopathy: an update.

Fadah K, Gopi G, Lingireddy A, Blumer V, Dewald T, Mentz R Front Cardiovasc Med. 2023; 10:1214374.

PMID: 37564909 PMC: 10412093. DOI: 10.3389/fcvm.2023.1214374.

References

Joseph J, Parr M . Synthetic androgens as designer supplements. Curr Neuropharmacol. 2015; 13(1):89-100. PMC: 4462045. DOI: 10.2174/1570159X13666141210224756. View

Gronbladh A, Nylander E, Hallberg M . The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone. Brain Res Bull. 2016; 126(Pt 1):127-137. DOI: 10.1016/j.brainresbull.2016.05.003. View

Lippi G, Franchini M, Banfi G . Biochemistry and physiology of anabolic androgenic steroids doping. Mini Rev Med Chem. 2011; 11(5):362-73. DOI: 10.2174/138955711795445952. View

Daina A, Michielin O, Zoete V . SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; 7:42717. PMC: 5335600. DOI: 10.1038/srep42717. View

Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

Benigni R, Bossa C . Predictivity and reliability of QSAR models: the case of mutagens and carcinogens. Toxicol Mech Methods. 2009; 18(2-3):137-47. DOI: 10.1080/15376510701857056. View

Fragkaki A, Angelis Y, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C . Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure. Steroids. 2008; 74(2):172-97. DOI: 10.1016/j.steroids.2008.10.016. View

Kicman A . Pharmacology of anabolic steroids. Br J Pharmacol. 2008; 154(3):502-21. PMC: 2439524. DOI: 10.1038/bjp.2008.165. View

van Amsterdam J, Opperhuizen A, Hartgens F . Adverse health effects of anabolic-androgenic steroids. Regul Toxicol Pharmacol. 2010; 57(1):117-23. DOI: 10.1016/j.yrtph.2010.02.001. View

10.

Hishigaki H, Kuhara S . hERGAPDbase: a database documenting hERG channel inhibitory potentials and APD-prolongation activities of chemical compounds. Database (Oxford). 2011; 2011:bar017. PMC: 3096323. DOI: 10.1093/database/bar017. View

11.

Grosdidier A, Zoete V, Michielin O . SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 2011; 39(Web Server issue):W270-7. PMC: 3125772. DOI: 10.1093/nar/gkr366. View

12.

Kersey R, Elliot D, Goldberg L, Kanayama G, Leone J, Pavlovich M . National Athletic Trainers' Association position statement: anabolic-androgenic steroids. J Athl Train. 2012; 47(5):567-88. PMC: 3465038. DOI: 10.4085/1062-6050-47.5.08. View

13.

Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G . admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012; 52(11):3099-105. DOI: 10.1021/ci300367a. View

14.

Grosdidier A, Zoete V, Michielin O . EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization. Proteins. 2007; 67(4):1010-25. DOI: 10.1002/prot.21367. View

15.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

16.

de Jesus-Tran K, Cote P, Cantin L, Blanchet J, Labrie F, Breton R . Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Sci. 2006; 15(5):987-99. PMC: 2242507. DOI: 10.1110/ps.051905906. View

17.

Cohen J, Collins R, Darkes J, Gwartney D . A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007; 4:12. PMC: 2131752. DOI: 10.1186/1550-2783-4-12. View

18.

Nieschlag E, Vorona E . MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015; 173(2):R47-58. DOI: 10.1530/EJE-15-0080. View

19.

Patlewicz G, Jeliazkova N, Safford R, Worth A, Aleksiev B . An evaluation of the implementation of the Cramer classification scheme in the Toxtree software. SAR QSAR Environ Res. 2008; 19(5-6):495-524. DOI: 10.1080/10629360802083871. View

20.

Hall R, Hall R . Abuse of supraphysiologic doses of anabolic steroids. South Med J. 2005; 98(5):550-5. DOI: 10.1097/01.SMJ.0000157531.04472.B2. View